ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

DQB1 Epitope Matching Predicts the Development of De Novo DSA and Antibody Mediated Rejection

M. Willicombe,1 M. Blow,2 P. Brookes,2 E. Santos,2 D. Taube.1

1Imperial College Kidney and Transplant Centre, Hammersmith Hospital, London, United Kingdom
2H&I, Hammersmith Hospital, London, United Kingdom.

Meeting: 2015 American Transplant Congress

Abstract number: A116

Keywords: Epitopes, HLA antibodies, HLA matching, Rejection

Session Information

Date: Saturday, May 2, 2015

Session Name: Poster Session A: Kidney Antibody Mediated Rejection

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Exhibit Hall E

Related Abstracts
  • Epitope Spreading and Epitope Sharing Are Involved in Acute IgG1 Antibody-Mediated Rejection of a Kidney Transplant with Disparity Only at HLA-DP
  • Epitope Matching Outperforms Traditional Antigen Matching as a Predictor of De Novo Donor Specific Antibody Development after Renal Transplantation

HLA DQ antibodies are the commonest de novo [DN] DSA specificity seen post renal transplantation. Their presence is associated with antibody mediated injury and allograft loss. However it is known that allorecognition is epitope rather than antigen dependent and that epitopes may be shared between two or more HLA antigens.

The aim of this study is determine the significance of DQ epitope mismatching in the development of DN DQ DSA. We retrospectively identified patients transplanted at our centre who had a single DQ antigen mismatch (MM) by low resolution typing. Epitopes were determined using Tersaki defined epitopes (TerEp). DSA were detected at times of allograft dysfunction and routine screening. 50/485[10.3%] of patients mismatched [MM] at a single DQ antigen developed a DQ DSA. The median TerEp MM was higher in the DSA+ [median 4(IQR:3-6)] compared with DSA- [median 3(IQR: 2-4)] patients, p<0.0001. By ROC analysis, patients MM at ≥4 epitopes were at risk of developing a DSA. DSA free survival was 87.1% and 66.1% in patients MM at ≤3 and ≥4 epitopes respectively, p<0.001. AMR risk was also increased in the ≥4 MM group but TG and allograft loss were not significantly different between the ≤3 and ≥4 groups as shown in the table 1.

Event free survival [%] TerEp <3 TerEp >4 p value
De novo DQ DSA 87.1% 66.1% <0.0001
Allograft loss 84.4% 89.9% 0.22
Rejection 69.6% 67.9% 0.26
AMR 90.9% 82.9% 0.041
TG 95.4% 89.5% 0.16

This study demonstrates that DQ epitope mismatching may predict the development of de novo DQ DSA and AMR in patients who have an equivalent mismatch by low resolution typing.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Willicombe M, Blow M, Brookes P, Santos E, Taube D. DQB1 Epitope Matching Predicts the Development of De Novo DSA and Antibody Mediated Rejection [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/dqb1-epitope-matching-predicts-the-development-of-de-novo-dsa-and-antibody-mediated-rejection/. Accessed April 22, 2021.

« Back to 2015 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.